Strona główna・Stock List・Inspire Medical Systems Inc

Inspire Medical Systems Inc

Closed

SectorHealthcare

59.36 -1.74

Buy Sell

Overview

Share price change

24h

Current

Min

59.46

Max

64.15

Key metrics
By Trading Economics
Income	12M 314K
Sales	-4M 201M
P/E Sector Avg	11.868 68.51
EPS	0.14
Profit margin	0.157
Employees	1,333
EBITDA	-8M -514K

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	-6.22% downside

Dividends
By Acuity
Next Earnings	2 lis 2026

Market Stats
By TradingEconomics
Market Cap	-75M 1.5B
Previous open	61.1
Previous close	59.36

News Sentiment

By Acuity

73%

27%

315 / 340 Ranking in Healthcare

Inspire Medical Systems Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

5 sie 2026, 20:02 UTC

Social Media

Inspire Medical Systems Inc shares are lower today despite a "BUY" rating upgrade. Broader market trends contribute to the decline since Tuesday's close.

4 sie 2026, 22:11 UTC

Inspire Medical Systems Inc shares declined in after-market trading following Tuesday's close, despite remaining above their 20-day moving average. No specific news was identified.

3 sie 2026, 23:21 UTC

News

Inspire Medical Systems reported Q2 adjusted EPS of $0.14, exceeding expectations. The company raised its full-year EPS guidance to between $1.05 and $1.45.

31 lip 2026, 19:46 UTC

News

Inspire Medical Systems faces sales decline concerns, projected at 8% over the next year. Shares are trading roughly flat since Thursday's close.

30 lip 2026, 20:09 UTC

Inspire Medical Systems Inc shares are lower amid broader market volatility following rising jobless claims and disappointing GDP growth data.

29 lip 2026, 19:03 UTC

Macro Event

Inspire Medical Systems Inc shares are lower as the Federal Reserve maintains interest rates, signaling ongoing economic uncertainties and potential volatility ahead.

28 lip 2026, 18:16 UTC

News

Inspire Medical shares are higher since Monday's close after announcing Michael H. Carrel's appointment to its Board of Directors, despite UBS initiating coverage with a Sell rating.

27 lip 2026, 19:51 UTC

News

Inspire Medical Systems shares are higher, bolstered by positive sentiment in Health Care Equipment and the appointment of Michael H. Carrel to its Board.

23 lip 2026, 19:46 UTC

Inspire Medical Systems Inc. shares are trading roughly flat, fluctuating within a narrow range since Wednesday's close, with no specific news identified.

22 lip 2026, 17:51 UTC

News

Inspire Medical Systems shares are lower amid broader Health Care Equipment declines and uncertainty following Casey M. Tansey's retirement from the Board of Directors.

21 lip 2026, 18:56 UTC

Inspire Medical Systems Inc shares are lower today, reaching a session low. The stock remains above its 20-day moving average despite the decline.

20 lip 2026, 18:01 UTC

Inspire Medical Systems shares are higher today amid broader market volatility, influenced by rising yields and oil prices surpassing $90 per barrel.

Peer Comparison

Price change

Inspire Medical Systems Inc Forecast

Price Target

By TipRanks

-6.22% downside

12 Months Forecast

Average 60.15 USD -6.22%

High 85 USD

Low 39 USD

Based on 14 Wall Street analysts offering 12 month price targets forInspire Medical Systems Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

14 ratings

Buy

Hold

Sell

Based on 14 analysts giving stock ratings to Inspire Medical Systems Inc - Dist in the past 3 months.

Sentiment

By Acuity

315 / 340 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.